Abcam, ab315301, Human Pro-GRP (31-98) ELISA Kit- intracellular

Size: 1 x 96Tests
Human Pro-GRP (31-98) ELISA Kit- intracellular is a single-wash 90-min Simplestep used to quantify Human Pro-GRP (31-98) with a sensitivity of 2.54 pg/ml. The assay uses a simple mix-wash-read protocol with just one incubation and one wash step. - Colorimetric Sandwich ELISA - 450 nm readout : works on any standard plate reader
Key facts
Detection method:Colorimetric,
Sample types:Cell Lysate,
Reacts with:Human,
Assay type:Sandwich (quantitative),
Sensitivity:= 2.54 pg/mL,
Range:7.5 - 480 pg/mL,
Assay time:1h 30m,
Assay Platform:Pre-coated microplate (12 x 8 well strips)

Product details:
Human Pro-GRP (31-98) SimpleStep ELISA
kit is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of Pro-GRP (31-98) protein in human serum, plasma, saliva and cell culture supernatant. Quantitate Human Pro-GRP (31-98) with 2.54 pg/ml sensitivity.
SimpleStep ELISA
technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA
plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA
protocol summary in the image section for further details. Our SimpleStep ELISA
technology provides several benefits:
-Single-wash protocol reduces assay time to 90 minutes or less
-High sensitivity, specificity and reproducibility from superior antibodies
-Fully validated in biological samples
-96-wells plate breakable into 12 x 8 wells strips
A 384-well SimpleStep ELISA
microplate (
ab315065
) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Properties and Storage Information:
Shipped at conditions-Blue Ice, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions-+4°C, Storage information-+4°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Pro-GRP (31-98) also known as Progastrin-releasing peptide is a peptide with a mass of approximately 8 kDa. It serves as a precursor for gastrin-releasing peptide (GRP). It undergoes cleavage to form the active GRP peptide. GRP belongs to the bombesin-like peptide family and you can primarily find it expressed in neuroendocrine tissues particularly in the gastrointestinal tract and lungs. This peptide plays an important role in various cellular signaling processes by binding to its receptors.
Biological function summary
The gastrin-releasing peptide influences the release of important hormones such as gastrin. It acts on the gastrointestinal system contributing to the stimulation of gastric acid secretion. Additionally GRP has a role in neurotransmission. It forms part of a signaling system that operates in neuroendocrine communication where it works with other neuropeptides to regulate physiological processes.
Pathways
The gastrin-releasing peptide impacts several signaling pathways including the gastrin secretion pathway and the bombesin receptor pathway. It interacts with receptors on target cells to induce cellular responses including growth and secretory functions. Related proteins like the bombesin receptor subtype 3 are involved in these pathways modulating different biochemical reactions that contribute to digestion and central nervous system signaling.
Gastrin-releasing peptide has associations with small cell lung cancer and gastrointestinal disorders. Elevated levels of Pro-GRP (31-98) can serve as a biomarker for small cell lung cancer aiding in diagnosis and monitoring treatment responses. The interplay of GRP with the bombesin receptor and related pathways like those involving gastrin underlines its importance in certain tumorigenic processes and dysregulation in gastrointestinal functions.